CII
SAGE

Capital International Inc’s Sage Therapeutics SAGE Stock Holding History

Capital International Inc’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,429
Closed -$1.3M – 307
2021
Q1 		$1.3M Sell
17,429
-669
-4% -$54.9K 0.01% 272
2020
Q4 		$1.57M Sell
18,098
-25,573
-59% -$1.88M 0.01% 252
2020
Q3 		$2.67M Buy
43,671
+22,494
+106% +$1.14M 0.03% 208
2020
Q2 		$881K Sell
21,177
-262,609
-93% -$9.53M 0.01% 233
2020
Q1 		$8.15M Buy
283,786
+15,053
+6% +$872K 0.14% 121
2019
Q4 		$19.4M Buy
268,733
+2,453
+0.9% +$302K 0.27% 104
2019
Q3 		$37.4M Buy
266,280
+249,273
+1,466% +$41.7M 0.56% 81
2019
Q2 		$3.11M Buy
+17,007
New +$2.9M 0.22% 100

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return